Purchase Order HHSN275201600625P

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $8,880.15 on August 9, 2016. Work was performed in Carlsbad, California. The order was firm fixed price with an ultimate completion date of January 31, 2021. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $4,332.33 on February 4, 2016, with completion on April 7, 2017. The order carries no set-aside designation. Performance occurs in Carlsbad, California. Life Technologies supplies scientific instruments, reagents, and consumables to federal agencies across research and medical sectors.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $19,460.00 on November 18, 2014, for preventive maintenance of a 7900HT sequence detection system (Serial Number 279003055). Work is performed in Carlsbad, California, with ultimate completion on November 19, 2015. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on September 15, 2017, valued at $58,800.00. This modification changed the vendor due to a novation agreement. Performance occurs in Carlsbad, California, with an ultimate completion date of February 28, 2018. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $9,442.70 on December 6, 2017, with completion by December 29, 2017. The order is for TaqMan OpenArray, a molecular biology consumable. Performance occurs in Grand Island, New York.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $13,095.76 on May 2, 2020, for equipment maintenance services. Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of May 1, 2021.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>